Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805,BJU International

当前位置： X-MOL 学术 › BJU Int. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805
BJU International ( IF 4.5 ) Pub Date : 2021-09-04 , DOI: 10.1111/bju.15587
Jose A Karam ₁ , Maneka Puligandla ₂ , Keith T Flaherty ₃ , Robert G Uzzo ₄ , Surena F Matin ₁ , Michael R Pins ₅ , Christopher G Wood ₁ , Christopher Kane ₆ , Michael A S Jewett ₇ , Se Eun Kim ₂ , Janice P Dutcher ₈ , Robert S DiPaola ₉ , Naomi B Haas _{4,

10}

Affiliation

To study the effects of adjuvant therapy in patients with sarcomatoid renal cell carcinoma (sRCC) enrolled in the randomised phase III clinical trial E2805.

中文翻译：